Nasdaq-100 & Reed Kathrein
9 shared events · Importance 6 · Last updated May 09, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Nasdaq-100: Gossamer Bio has not met the minimum share bid price required for continued listing on the Nasdaq Global Select Market, indicating a potential delisting.
Reed Kathrein: Reed Kathrein is the Hagens Berman partner leading the firm's investigation into Gossamer Bio's alleged misleading disclosures.
Apr 01, 2026 · 103 articles
Business
Nasdaq-100: Nasdaq-100 issued a deficiency notice to Driven Brands for its failure to timely file financial reports, potentially leading to delisting if compliance is not regained.
Reed Kathrein: Reed Kathrein is the Hagens Berman partner leading the firm's investigation into the claims against Driven Brands.
Apr 23, 2026 · 19 articles
Business
Nasdaq-100: Gossamer Bio faces potential delisting from Nasdaq-100 Global Select Market due to not meeting the minimum share bid price requirement.
Reed Kathrein: Reed Kathrein is the Hagens Berman partner leading the firm's investigation into Gossamer Bio's alleged misleading disclosures.
Apr 28, 2026 · 6 articles
Business
Nasdaq-100: Nasdaq-100 is the stock exchange where ODDITY Tech securities are traded.
Reed Kathrein: Reed Kathrein is a partner at Hagens Berman leading the firm's investigation into ODDITY Tech's alleged securities law violations.
Apr 01, 2026 · 93 articles
Business
Nasdaq-100: Nasdaq-100 is the stock exchange where MiNK Therapeutics' common stock is traded, providing the platform for the securities involved in the class action.
Reed Kathrein: Reed Kathrein is a partner at Hagens Berman leading the firm's investigation into the alleged claims against MiNK Therapeutics.
Apr 01, 2026 · 83 articles
NEWSDESK
Explore this relationship live
Track how Nasdaq-100 and Reed Kathrein interact across events, view sentiment trends, and discover connected entities.
Open Dashboard